UBS AM’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-270,559
| Closed | -$576K | – | 2641 |
|
|
2024
Q4 | $576K | Buy |
270,559
+41,753
| +18% | +$88.9K | ﹤0.01% | 2531 |
|
|
2024
Q3 | $641K | Sell |
228,806
-37,978
| -14% | -$106K | ﹤0.01% | 2578 |
|
|
2024
Q2 | $622K | Buy |
266,784
+96,497
| +57% | +$225K | ﹤0.01% | 2566 |
|
|
2024
Q1 | $761K | Buy |
170,287
+13,578
| +9% | +$60.7K | ﹤0.01% | 2148 |
|
|
2023
Q4 | $503K | Hold |
156,709
| – | – | ﹤0.01% | 2318 |
|
|
2023
Q3 | $497K | Sell |
156,709
-376,527
| -71% | -$1.19M | ﹤0.01% | 2305 |
|
|
2023
Q2 | $2.63M | Hold |
533,236
| – | – | ﹤0.01% | 1526 |
|
|
2023
Q1 | $2.63M | Buy |
+533,236
| New | +$2.63M | ﹤0.01% | 1526 |
|
|
2022
Q4 | – | Sell |
-506,137
| Closed | -$5.47M | – | 2546 |
|
|
2022
Q3 | $5.47M | Buy |
506,137
+79,855
| +19% | +$862K | ﹤0.01% | 1167 |
|
|
2022
Q2 | $4.86M | Buy |
426,282
+23,425
| +6% | +$267K | ﹤0.01% | 1223 |
|
|
2022
Q1 | $3.67M | Buy |
402,857
+12,895
| +3% | +$117K | ﹤0.01% | 1488 |
|
|
2021
Q4 | $5.82M | Buy |
389,962
+2,021
| +0.5% | +$30.2K | ﹤0.01% | 1350 |
|
|
2021
Q3 | $9.97M | Sell |
387,941
-10,239
| -3% | -$263K | ﹤0.01% | 1099 |
|
|
2021
Q2 | $10.4M | Buy |
398,180
+172,689
| +77% | +$4.5M | ﹤0.01% | 1110 |
|
|
2021
Q1 | $7.91M | Sell |
225,491
-38,814
| -15% | -$1.36M | ﹤0.01% | 1160 |
|
|
2020
Q4 | $6.67M | Buy |
264,305
+3,961
| +2% | +$100K | ﹤0.01% | 1184 |
|
|
2020
Q3 | $9.82M | Buy |
260,344
+13,933
| +6% | +$525K | 0.01% | 948 |
|
|
2020
Q2 | $10.6M | Buy |
246,411
+63,727
| +35% | +$2.73M | 0.01% | 889 |
|
|
2020
Q1 | $3.55M | Sell |
182,684
-21,628
| -11% | -$420K | ﹤0.01% | 1190 |
|
|
2019
Q4 | $5.31M | Buy |
204,312
+9,226
| +5% | +$240K | ﹤0.01% | 1165 |
|
|
2019
Q3 | $5.32M | Sell |
195,086
-5,181
| -3% | -$141K | ﹤0.01% | 1183 |
|
|
2019
Q2 | $5.38M | Buy |
200,267
+2,142
| +1% | +$57.5K | ﹤0.01% | 1173 |
|
|
2019
Q1 | $5.73M | Buy |
198,125
+102,303
| +107% | +$2.96M | ﹤0.01% | 1102 |
|
|
2018
Q4 | $2.58M | Buy |
+95,822
| New | +$2.58M | ﹤0.01% | 1323 |
|